Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856641) titled 'Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients' on Sept. 28.
Study Type: Observational
Primary Sponsor: The University of Texas Health Science Center, Houston
Condition:
Circadian Variation in Anti-Factor Xa (Anti-FXa) Activity
Recruitment Status: Recruiting
Date of First Enrollment: August 26, 2026
Target Sample Size: 40
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07856641
Published by HT Digital Content Services with permission from Health Daily Digest....